Scout Bio, Penn gene therapy firm, gets $9.29M from Frazier – Philly.com
Philly.com |
Scout Bio, Penn gene therapy firm, gets $9.29M from Frazier
Philly.com After the Frazier-led share purchase, Scout Bio directors include Penn medical school vice dean Kevin Mahoney, who succeeds pioneering Penn gene therapy developer Dr. James Wilson, who co-registered the company in Massachusetts in 2016; Krishna Polu, a … |
